Literature DB >> 508983

[The prognostic value of haemodynamic tests in chronic bronchitis (author's transl)].

N Massin, J C Westphal, F Schrijen, J M Polu, P Sadoul.   

Abstract

The prognostic value of several functional respiratory and haemodynamic variables was studied in a group of 212 patients with chronic bronchitis, who were examined in steady state, without cardiac or respiratory failure, at rest and when possible during moderate exercise (195 patients). Follow-up interval ranged from 5 to 12 years. Results were processed using two methods: estimation of actuarial survival rate and discriminant analysis. Survival rate curves for the patients showed a reduction relative to the general population of the same ages: 74% within five years compared to 91% in the general population, 56% within nine years compared to 82%. Survival rate was significantly lower in patients with PPA above 30 mmHg, or driving pressure (PPA--PW) above 15 mmHg, or pulmonary vascular resistance higher than 210 dyn . s . cm-5, or when PPA increased more than 10 mmHg during exercise. Discriminant analysis underlined the predictive value of three haemodynamic variables: PPA change from rest to exercise, pressure developed by the right heart (PPA--PRVED) and stroke volume: together, they predict the death of 3 over 4 patients with the criteria chosen.

Entities:  

Mesh:

Year:  1979        PMID: 508983

Source DB:  PubMed          Journal:  Bull Eur Physiopathol Respir        ISSN: 0395-3890


  3 in total

1.  Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.

Authors:  E Weitzenblum; C Hirth; A Ducolone; R Mirhom; J Rasaholinjanahary; M Ehrhart
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

2.  Effect of single lung transplantation on pulmonary hypertension in patients with end stage fibrosing lung disease.

Authors:  J C Doig; P A Corris; C J Hilton; J H Dark; R S Bexton
Journal:  Br Heart J       Date:  1991-12

3.  [Lung volume reduction in severe emphysema].

Authors:  S Demertzis; H Wilkens; H J Schäfers
Journal:  Med Klin (Munich)       Date:  1997-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.